Home > Insider Trading > Filing (0001209191-14-041442)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131324	Genomic Health Inc	GHDX	Services-Medical Laboratories (8071)	770552594

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509688	L Dean Schorno	301 Penobscot Drive Redwood City CA 94063	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-06-10	2,000	$17.18	26,524	No	4	M	Direct
Common Stock	Acquisiton	2014-06-10	2,000	$18.89	28,524	No	4	M	Direct
Common Stock	Disposition	2014-06-10	4,000	$27.62	24,524	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Sstock	Employee Stock Option (right to buy)	Disposition	2014-06-10	2,000	$0.00	2,000	$18.89
Common Stock	Employee Stock Option (right to buy)	Disposition	2014-06-10	2,000	$0.00	2,000	$17.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,000		2016-11-30	No	4	M	Direct
7,152		2020-02-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,149	Indirect	By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA

Footnotes

These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 10, 2014.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $27.15 to $27.92.
Includes an aggregate of 7,585 shares of common stock issuable pursuant to previously reported restricted stock unit awards that have not vested.
The option became exercisable as to 25% of the shares on November 30, 2007, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on February 18, 2011, and becomes exercisable as to 1/48th of the shares each full month thereafter.